AR008386A1 - DERIVADOS DE BENZIMIDAZOL CON ACTIVIDAD ANTIHISTAMINICA Y COMPOSICIoN FARMACÉUTICA ANTIHISTAMINICA QUE LOS CONTIENE. - Google Patents

DERIVADOS DE BENZIMIDAZOL CON ACTIVIDAD ANTIHISTAMINICA Y COMPOSICIoN FARMACÉUTICA ANTIHISTAMINICA QUE LOS CONTIENE.

Info

Publication number
AR008386A1
AR008386A1 ARP970102441A ARP970102441A AR008386A1 AR 008386 A1 AR008386 A1 AR 008386A1 AR P970102441 A ARP970102441 A AR P970102441A AR P970102441 A ARP970102441 A AR P970102441A AR 008386 A1 AR008386 A1 AR 008386A1
Authority
AR
Argentina
Prior art keywords
antihistamine
pharmaceutical composition
composition containing
benzimidazole derivatives
activity
Prior art date
Application number
ARP970102441A
Other languages
English (en)
Spanish (es)
Original Assignee
Faes Farma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faes Farma Sa filed Critical Faes Farma Sa
Publication of AR008386A1 publication Critical patent/AR008386A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ARP970102441A 1996-06-04 1997-06-05 DERIVADOS DE BENZIMIDAZOL CON ACTIVIDAD ANTIHISTAMINICA Y COMPOSICIoN FARMACÉUTICA ANTIHISTAMINICA QUE LOS CONTIENE. AR008386A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09601236A ES2124167B1 (es) 1996-06-04 1996-06-04 Nuevos derivados del bencimidazol con actividad antihistaminica.

Publications (1)

Publication Number Publication Date
AR008386A1 true AR008386A1 (es) 2000-01-19

Family

ID=8295035

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970102441A AR008386A1 (es) 1996-06-04 1997-06-05 DERIVADOS DE BENZIMIDAZOL CON ACTIVIDAD ANTIHISTAMINICA Y COMPOSICIoN FARMACÉUTICA ANTIHISTAMINICA QUE LOS CONTIENE.

Country Status (27)

Country Link
US (1) US5877187A (cg-RX-API-DMAC7.html)
EP (1) EP0818454B1 (cg-RX-API-DMAC7.html)
JP (1) JP4218991B2 (cg-RX-API-DMAC7.html)
CN (1) CN1105716C (cg-RX-API-DMAC7.html)
AR (1) AR008386A1 (cg-RX-API-DMAC7.html)
AT (1) ATE264317T1 (cg-RX-API-DMAC7.html)
AU (1) AU725700B2 (cg-RX-API-DMAC7.html)
BR (1) BR9703276A (cg-RX-API-DMAC7.html)
CA (1) CA2206754C (cg-RX-API-DMAC7.html)
CZ (1) CZ289278B6 (cg-RX-API-DMAC7.html)
DE (2) DE69728608T2 (cg-RX-API-DMAC7.html)
DK (1) DK0818454T3 (cg-RX-API-DMAC7.html)
ES (1) ES2124167B1 (cg-RX-API-DMAC7.html)
FR (1) FR11C0023I2 (cg-RX-API-DMAC7.html)
HR (1) HRP970307B1 (cg-RX-API-DMAC7.html)
HU (1) HU227598B1 (cg-RX-API-DMAC7.html)
IN (1) IN186319B (cg-RX-API-DMAC7.html)
LU (1) LU91798I2 (cg-RX-API-DMAC7.html)
MX (1) MXPA97004127A (cg-RX-API-DMAC7.html)
NO (2) NO313195B1 (cg-RX-API-DMAC7.html)
PL (1) PL188908B1 (cg-RX-API-DMAC7.html)
PT (1) PT818454E (cg-RX-API-DMAC7.html)
RU (1) RU2182150C2 (cg-RX-API-DMAC7.html)
SI (1) SI0818454T1 (cg-RX-API-DMAC7.html)
TR (1) TR199700464A3 (cg-RX-API-DMAC7.html)
TW (1) TW438794B (cg-RX-API-DMAC7.html)
ZA (1) ZA974893B (cg-RX-API-DMAC7.html)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9911752A (pt) 1998-07-01 2001-04-03 Takeda Chemical Industries Ltd Agente de regulagem da função do receptor relacionado com a retinóide, derivados de oxazol, de imidazol e de tiazol, composto, processo para regular uma função de receptor relacionado com a retinóide, e, uso de um derivado
HUP0200749A3 (en) 1998-11-27 2003-03-28 Basf Ag Substituted benzimidazoles and their use as parp inhibitors and process for their preparation
ES2151442B1 (es) * 1999-01-11 2001-07-01 Espanola Prod Quimicos Nuevo derivado del bencenoetanol.
US6826561B2 (en) 2000-05-22 2004-11-30 Broadcom Corporation Method and apparatus for performing a binary search on an expanded tree
EP1505066B1 (en) * 2002-04-19 2006-12-06 Faes Farma, S.A. Polymorph of acid 4-[2-[4-[1-(2-ethoxyethyl)-1h-benzimidazole-2-il]-1-piperidinyl]ethyl]-alpha, alpha-dimethyl-benzeneacetic
RU2288917C2 (ru) * 2002-04-19 2006-12-10 Фаэс Фарма, С.А. Полиморф 4-[2-[4-[1-(2-этоксиэтил)-1h-бензимидазол-2-ил]-1-пиперидинил]этил]-альфа, альфа-диметилбензолуксусной кислоты, способ его получения, фармацевтический препарат на его основе и его применение
EP1511482B1 (en) * 2002-06-13 2006-11-15 Vertex Pharmaceuticals Incorporated 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections
US20070188330A1 (en) * 2006-01-24 2007-08-16 Morhard Robert C System and method for detecting, monitoring, tracking and identifying explosive materials using ID marks
US7247623B2 (en) * 2005-08-19 2007-07-24 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with non-drying antihistamines
KR101123903B1 (ko) 2008-02-12 2012-03-23 주식회사유한양행 2-메틸-2'-페닐프로피온산 유도체의 제조 방법 및 이에 사용되는 신규한 중간체 화합물
JP2010013472A (ja) * 2009-09-09 2010-01-21 Faes Farma Sa ４−［２−［１−（２−エトキシエチル）−１Ｈ−ベンズイミダゾール−２−イル］−１−ピペリジニル］エチル］−α，α−ジメチルベンゼノ酢酸の多形体
CN102675101B (zh) * 2012-05-16 2014-01-29 王蕾 2-(4-卤乙基)苯基-2-甲基丙酸酯的制备方法及合成比拉斯汀的方法
CZ307500B6 (cs) 2012-08-15 2018-10-24 Zentiva, K.S. Způsob přípravy derivátu 2-methyl-2´-fenylpropionové kyseliny využívající nové intermediáty
WO2014149019A1 (en) * 2013-03-15 2014-09-25 Hercules Incorporated Composition and method of producing personal care compositions with improved deposition properties
CN103214454A (zh) * 2013-03-30 2013-07-24 北京万全德众医药生物技术有限公司 一种比拉斯汀晶型及制备方法
CN103214455B (zh) * 2013-03-30 2018-08-31 北京万全德众医药生物技术有限公司 一种比拉斯汀的制备方法
WO2014188453A2 (en) * 2013-05-24 2014-11-27 Msn Laboratories Private Limited Novel process for the preparation of 2-[4-(2-{4-[1-(2-ethoxyethyl)-1h-benzimidazol-2-yl]-1-piperidinyl}ethyl) phenyl]-2-methylpropanoic acid
CN103351380B (zh) * 2013-06-30 2019-01-22 北京万全德众医药生物技术有限公司 一种制备比拉斯汀的方法
CN104447683A (zh) * 2013-09-12 2015-03-25 天津市汉康医药生物技术有限公司 一种稳定的比拉斯汀化合物
CN103896915A (zh) * 2014-04-01 2014-07-02 中国药科大学 苯并咪唑类衍生物、其制备方法及其在医药上的应用
EP3040334A1 (en) 2014-12-29 2016-07-06 Faes Farma, S.A. New benzimidazole derivatives as antihistamine agents
CN106349214B (zh) * 2015-07-13 2020-11-03 南京长澳医药科技有限公司 一种比拉斯汀杂质的制备方法
ES2600827B9 (es) * 2015-07-24 2018-03-28 Urquima, S.A Formas cristalinas de bilastina y procedimientos para su preparación
CN105272977A (zh) * 2015-09-19 2016-01-27 万全万特制药江苏有限公司 一种制备比拉斯汀中间体的方法
EP3170816A1 (en) 2015-11-20 2017-05-24 Faes Farma, S.A. Supersaturated compositions of benzimidazole compounds
EP3170817A1 (en) 2015-11-20 2017-05-24 Faes Farma, S.A. Co-crystals of benzimidazole compounds
WO2017167949A1 (en) 2016-04-01 2017-10-05 Krka, D.D., Novo Mesto Crystalline forms of bilastine
WO2017191651A1 (en) * 2016-05-05 2017-11-09 Msn Laboratories Private Limited, R & D Center Solid state forms of 2-[4-(2-{4-[1-(2-ethoxyethyl)-1h-benzimidazol-2-yl]-1-piperidinyl}ethyl)phenyl]-2-methylpropanoic acid and process for preparation thereof
CN107365298A (zh) * 2017-03-14 2017-11-21 罗欣生物科技（上海）有限公司 一种2‑甲基‑2’‑苯基丙酸衍生物的制备方法
CN109456316A (zh) * 2017-09-06 2019-03-12 万全万特制药江苏有限公司 一种比拉斯汀杂质的制备方法
ES2813561T3 (es) 2017-09-07 2021-03-24 Tiefenbacher Alfred E Gmbh & Co Kg Composición farmacéutica en comprimido que comprende bilastina
DK3681475T3 (da) 2017-10-16 2021-02-01 Faes Farma Sa Vandige sammensætninger omfattende bilastin og mometason
PL3641735T3 (pl) 2017-12-18 2021-09-06 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Kompozycja farmaceutyczna tabletki zawierająca bilastynę w postaci 3 i rozpuszczalny w wodzie wypełniacz
ES2835287T3 (es) 2017-12-18 2021-06-22 Tiefenbacher Alfred E Gmbh & Co Kg Composición farmacéutica de comprimido que comprende la forma polimórfica 3 de bilastina y aluminometasilicato de magnesio
EP3915539A1 (en) 2018-01-18 2021-12-01 Faes Farma, S.A. Ophthalmic compositions comprising bilastine, a beta-cyclodextrin and at least one gelling agent
CN109081827A (zh) * 2018-11-06 2018-12-25 北京天弘天达医药科技股份有限公司 一种比拉斯汀的制备方法及应用
EP3725298A1 (en) 2019-04-16 2020-10-21 Faes Farma, S.A. Stable and preserved pharmaceutical compositions of bilastine
EP4188339A1 (en) 2020-07-30 2023-06-07 Faes Farma, S.A. Decongestant drug delivery system
CN112110893A (zh) * 2020-10-28 2020-12-22 山东齐环医药科技有限公司 一种比拉斯汀的制备方法
JP2023549381A (ja) 2020-11-18 2023-11-24 バイオファーマ・シナジーズ，エス．エル． 抗ヒスタミン活性化合物を含む口内分散性粉末組成物
CA3200779A1 (en) 2020-12-23 2022-06-30 Strusi ORAZIO LUCA A non-micronized bilastine composition
CA3243849A1 (en) 2022-02-17 2023-08-24 Faes Farma, S.A. COMPOSITION OF BILASTIN FOR ONCE-DAILY PARENTERAL ADMINISTRATION
WO2024224326A1 (en) * 2023-04-27 2024-10-31 Leiutis Pharmaceuticals Llp Liquid parenteral formulations of bilastine
WO2024224308A1 (en) * 2023-04-27 2024-10-31 Leiutis Pharmaceuticals Llp Liquid parenteral formulations of bilastine free of cyclodextrins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8904174D0 (en) * 1989-02-23 1989-04-05 British Bio Technology Compounds
EP0525129A4 (en) * 1990-04-13 1993-03-24 Smith-Kline Beecham Corporation Substituted benzimidazoles
ES2048109B1 (es) * 1992-07-20 1994-12-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol.
FI950467L (fi) * 1992-08-03 1995-03-31 Sepracor Inc Terfenadiinin metaboliitit ja niiden optisesti puhtaat isomeerit allergisten sairauksien hoitamiseksi
CN1168717C (zh) * 1993-06-25 2004-09-29 默里尔药物公司 用于制备抗组胺哌啶衍生物的新中间体

Also Published As

Publication number Publication date
PL320358A1 (en) 1997-12-08
PL188908B1 (pl) 2005-05-31
IN186319B (cg-RX-API-DMAC7.html) 2001-08-04
US5877187A (en) 1999-03-02
HU9700997D0 (en) 1997-07-28
EP0818454B1 (en) 2004-04-14
JPH1059961A (ja) 1998-03-03
CA2206754C (en) 2007-01-23
AU2467297A (en) 1997-12-11
EP0818454A1 (en) 1998-01-14
ES2124167A1 (es) 1999-01-16
BR9703276A (pt) 2004-08-17
MXPA97004127A (es) 2005-07-25
JP4218991B2 (ja) 2009-02-04
PT818454E (pt) 2004-08-31
TR199700464A2 (xx) 1997-12-21
SI0818454T1 (en) 2004-08-31
CN1105716C (zh) 2003-04-16
HRP970307B1 (en) 2002-02-28
HU227598B1 (en) 2011-09-28
NO972525L (no) 1997-12-05
TR199700464A3 (tr) 1997-12-21
FR11C0023I2 (fr) 2012-03-16
HUP9700997A1 (hu) 1999-09-28
ES2124167B1 (es) 1999-09-16
NO2011008I2 (no) 2012-05-14
CZ172397A3 (en) 1997-12-17
ZA974893B (en) 1997-12-30
DE122011000006I1 (de) 2011-06-16
NO313195B1 (no) 2002-08-26
CZ289278B6 (cs) 2001-12-12
NO972525D0 (no) 1997-06-03
HRP970307A2 (en) 1998-04-30
DE69728608T2 (de) 2005-04-21
CA2206754A1 (en) 1997-12-04
TW438794B (en) 2001-06-07
ATE264317T1 (de) 2004-04-15
AU725700B2 (en) 2000-10-19
RU2182150C2 (ru) 2002-05-10
DE69728608D1 (de) 2004-05-19
FR11C0023I1 (cg-RX-API-DMAC7.html) 2011-08-19
CN1176964A (zh) 1998-03-25
LU91798I2 (fr) 2011-05-23
NO2011008I1 (no) 2011-06-06
DK0818454T3 (da) 2004-07-12

Similar Documents

Publication Publication Date Title
AR008386A1 (es) DERIVADOS DE BENZIMIDAZOL CON ACTIVIDAD ANTIHISTAMINICA Y COMPOSICIoN FARMACÉUTICA ANTIHISTAMINICA QUE LOS CONTIENE.
AR029216A1 (es) Compuestos inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias; composicion farmaceutica y procedimiento de tratamiento
IT1264451B1 (it) 3-(carbossimetossifenil)-benzofuran-2-oni come agenti stabilizzanti
PE20010286A1 (es) Derivados de indoloxoacetil piperazina como agentes antivirales
IT1264452B1 (it) 3- (acilossifenil) benzofuran-2-oni come agenti stabilizzanti
NZ189418A (en) Propanolamine and morpholine derivatives pharmaceutical compositions
ATE327977T1 (de) Tetrahydrochinolin-derivate als crth2 antagonisten
ES2230719T3 (es) Compuestos basados en azabencimidazol para modular una funcion de proteina-quinasa de serina/treonina.
ECSP066967A (es) Derivados de tetrahidroquinolina y un procedimiento para preparar los mismos
AU2003301020A1 (en) Isoquinolinone derivatives and their use as therapeutic agents
PA8480101A1 (es) Derivados de quinolin-2-ona alquinilsustituidos utiles como agentes anticancerosos
ES2196806T3 (es) Derivados de fenilurea y de feniltiourea.
AR029634A1 (es) Compuestos derivados heterociclicos utiles como agentes anticancerosos, composicion farmaceutica y procedimiento de tratamiento
ES2095976T3 (es) Compuestos de pirazolopiridina y procedimiento para su preparacion.
ES2169248T3 (es) Compuestos aromaticos y composiciones farmaceuticas que los contienen.
ATE25682T1 (de) Indol-3-carboxamid-derivate.
AR024998A1 (es) Nuevos retinoides para el tratamiento del enfisema
AR007021A1 (es) Derivados de 3-descladinosa-2,3-anhidroeritromicina, procedimientos para su preparacion, compuestos para su exclusivo uso en dichos procedimientosy procedimiento para su preparacion, una composicion farmaceutica para tratar infecciones bacterianas y el uso de estos compuestos para preparar medicamentos
PA8586801A1 (es) Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
ATE239722T1 (de) Benzofurylpiperazine als serotonin-agonisten
ES2153019T3 (es) Derivados de benzo-dioxano, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
AR025351A1 (es) Agonistas retinoides selectivos par
AR027578A1 (es) Derivados de indano
DK0529450T3 (da) Substituerede mandelsyrederivater som 5-lipoxygenasehæmmere
MX9305719A (es) Agente antiarritmico.

Legal Events

Date Code Title Description
FG Grant, registration